457 related articles for article (PubMed ID: 32103345)
61. Hypersensitivity to calcitonin gene-related peptide in chronic migraine.
Iljazi A; Ashina H; Zhuang ZA; Lopez Lopez C; Snellman J; Ashina M; Schytz HW
Cephalalgia; 2021 May; 41(6):701-710. PubMed ID: 33322922
[TBL] [Abstract][Full Text] [Related]
62. Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.
Eftekhari S; Warfvinge K; Blixt FW; Edvinsson L
J Pain; 2013 Nov; 14(11):1289-303. PubMed ID: 23958278
[TBL] [Abstract][Full Text] [Related]
63. Is calcitonin gene-related peptide (CGRP) the missing link in food histamine-induced migraine? A review of functional gut-to-trigeminovascular system connections.
de Mora F; Messlinger K
Drug Discov Today; 2024 Apr; 29(4):103941. PubMed ID: 38447930
[TBL] [Abstract][Full Text] [Related]
64. Calcitonin gene-related peptide and migraine.
Karsan N; Goadsby PJ
Curr Opin Neurol; 2015 Jun; 28(3):250-4. PubMed ID: 25887765
[TBL] [Abstract][Full Text] [Related]
65. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
66. Differences in pituitary adenylate cyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascular system.
Edvinsson JCA; Grell AS; Warfvinge K; Sheykhzade M; Edvinsson L; Haanes KA
Cephalalgia; 2020 Oct; 40(12):1296-1309. PubMed ID: 32486909
[TBL] [Abstract][Full Text] [Related]
67. Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus.
Sixt ML; Messlinger K; Fischer MJ
Brain; 2009 Nov; 132(Pt 11):3134-41. PubMed ID: 19737844
[TBL] [Abstract][Full Text] [Related]
68. Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series.
Iannone LF; Fattori D; Geppetti P; De Cesaris F
Neurol Sci; 2022 Jan; 43(1):697-703. PubMed ID: 34586542
[TBL] [Abstract][Full Text] [Related]
69. Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients.
Fanciullacci M; Alessandri M; Sicuteri R; Marabini S
Brain; 1997 Feb; 120 ( Pt 2)():283-8. PubMed ID: 9117375
[TBL] [Abstract][Full Text] [Related]
70. Delta opioid receptor regulation of calcitonin gene-related peptide dynamics in the trigeminal complex.
Moye LS; Siegersma K; Dripps I; Witkowski W; Mangutov E; Wang D; Scherrer G; Pradhan AA
Pain; 2021 Aug; 162(8):2297-2308. PubMed ID: 33605657
[TBL] [Abstract][Full Text] [Related]
71. The Anti-Calcitonin Gene-Related Peptide (Anti-CGRP) Antibody Fremanezumab Reduces Trigeminal Neurons Immunoreactive to CGRP and CGRP Receptor Components in Rats.
Vogler B; Kuhn A; Mackenzie KD; Stratton J; Dux M; Messlinger K
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686275
[TBL] [Abstract][Full Text] [Related]
72. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
Kamm K; Straube A; Ruscheweyh R
Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
[TBL] [Abstract][Full Text] [Related]
73. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.
Durham PL
Headache; 2008 Sep; 48(8):1269-75. PubMed ID: 18808507
[TBL] [Abstract][Full Text] [Related]
74. Association study of the calcitonin gene-related polypeptide-alpha (CALCA) and the receptor activity modifying 1 (RAMP1) genes with migraine.
Sutherland HG; Buteri J; Menon S; Haupt LM; Macgregor EA; Lea RA; Griffiths LR
Gene; 2013 Feb; 515(1):187-92. PubMed ID: 23237777
[TBL] [Abstract][Full Text] [Related]
75. Excitatory Effects of Calcitonin Gene-Related Peptide (CGRP) on Superficial Sp5C Neurons in Mouse Medullary Slices.
Zheng F; Nixdorf-Bergweiler BE; van Brederode J; Alzheimer C; Messlinger K
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917574
[TBL] [Abstract][Full Text] [Related]
76. Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.
Link AS; Kuris A; Edvinsson L
J Headache Pain; 2008 Feb; 9(1):5-12. PubMed ID: 18217201
[TBL] [Abstract][Full Text] [Related]
77. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
Durham PL; Vause CV
CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
[TBL] [Abstract][Full Text] [Related]
78. CGRP blockers in migraine therapy: where do they act?
Edvinsson L
Br J Pharmacol; 2008 Dec; 155(7):967-9. PubMed ID: 18776915
[TBL] [Abstract][Full Text] [Related]
79. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
[TBL] [Abstract][Full Text] [Related]
80. Interplay of Oral, Mandibular, and Facial Disorders and Migraine.
Teruel A; Romero-Reyes M
Curr Pain Headache Rep; 2022 Jul; 26(7):517-523. PubMed ID: 35567662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
